logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Li Zhu Pharmaceuticals (01513.HK) spent about 4.9992 million yuan to repurchase 125,500 shares of A shares on September 17th.

date
17/09/2025
Zh tng cijng APP xn, l zh yyo (01513.HK) gngb, 2025 nin 9 yu 17 r ho z yu 499.92 wn yun hugu 12.55 wn g A g fn. According to the Financial Channel APP, Li Zhu Pharmaceutical (01513.HK) announced that on September 17, 2025, it will spend approximately 4,999,200 yuan to repurchase 125,000 shares of A shares.
Latest
1 m ago
LYFT's stock price rose 15% in pre-market trading.
1 m ago
LYFT's stock price rose 15% in pre-market trading.
1 m ago
Huachuang Cloud Message: Huachuang Securities is actively promoting efforts to drive the qualification of Pacific Securities shareholders.
1 m ago
Before the opening of the U.S. stock market on Wednesday, Johnson & Johnson's stock price slightly increased, following reports that the company's experimental psoriasis drug showed potential superiority over the treatment from AbbVie's Humira.
1 m ago
Before the market opens on Wednesday, the stock price of Johnson & Johnson has slightly increased. Earlier reports indicated that the company's experimental psoriasis drug showed potential superiority over the treatment of Pfizer's Stelara.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.